Abstract: The invention relates to a new group of snake venom basic protease inhibitors having vasopressin-2 receptor antagonist activity that can be used in therapy, diagnosis, medical imaging, drug screening and research.
Type:
Grant
Filed:
September 17, 2013
Date of Patent:
April 25, 2017
Assignees:
COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), UNIVERSITY OF REGENSBURG, UNIVERSITY DE LIEGE
Inventors:
Nicolas Gilles, Denis Servent, Loïc Quinton, Helen Reinfrank, Ralph Witzgall, Bernard Mouillac, Christiane Mendre
Abstract: The present invention relates to the field of degradation with hyperthermophilic organisms, and in particular to the use of hyperthermophilic degradation to produce heat and energy rich components including hydrogen and ethanol from a biomass. In some embodiments, a biomass is fermented in the presence of hyperthermophilic organisms to produce heat. The heat is used to heat a liquid which is used directly in a heat pump or radiant heat or to produce electricity or drive a steam turbine. In some embodiments, acetate is utilized as a substrate to produce energy by methanogenesis.
Abstract: Disclosed is a method for identifying an individual who has an altered risk for developing age-related macular degeneration comprising detecting an insertion/deletion polymorphism in the ARMS2 gene
Type:
Application
Filed:
March 28, 2012
Publication date:
August 2, 2012
Applicant:
UNIVERSITY OF REGENSBURG
Inventors:
Bernhard H.F. Weber, Thomas Loenhardt, Andrea Milenkovic, Lars G. Fritsche
Abstract: Disclosed is a method for identifying an individual who has an altered risk for developing age-related macular degeneration comprising detecting an insertion/deletion polymorphism in the ARMS2 gene.
Type:
Grant
Filed:
May 27, 2009
Date of Patent:
May 1, 2012
Assignee:
University of Regensburg
Inventors:
Bernhard H. F. Weber, Thomas Loenhardt, Andrea Milenkovic, Lars G. Fritsche
Abstract: Disclosed is a method for identifying an individual who has an altered risk for developing age-related macular degeneration comprising detecting an insertion/deletion polymorphism in the ARMS2 gene
Type:
Application
Filed:
May 27, 2009
Publication date:
December 2, 2010
Applicant:
UNIVERSITY OF REGENSBURG
Inventors:
Bernhard H.F. Weber, Thomas Loenhardt, Andrea Milenkovic, Lars G. Fritsche